
North Dakota Governor Signs Cannabis-Infused Edible Products Legislation into Law
North Dakota Governor Kelly Armstrong recently signed legislation enabling patients to purchase cannabis-infused products.
Recently in North Dakota, Governor Kelly Armstrong
The new bill entitles patients the ability to obtain “cannabinoid edible products”. According to the new bill, these products are determined to be “soft or hard lozenges in a geometric square shape into which a cannabinoid concentrate or the dried leaves or flowers of the plant of the genus cannabis is incorporated,” (1,2). Tetrahydrocannabinol (THC) content has been deemed to be allowable at nothing over 5 mg per serving and 50 mg per package. Currently, patients in the Peace Garden State are only able to obtain botanical cannabis and/or tinctures, topical patches, and capsules.
North Dakota’s medical cannabis access program consists of around 10,000 patients since it’s approval back in 2016 (1).
The bill mentions (2), “1) During a thirty-day period a registered qualifying patient may not purchase or have purchased by a registered designated caregiver more than six ounces [170.01 grams] of dried leaves or flowers of the plant of genus cannabis in a combustible delivery form. (2) At any time a registered qualifying patient, or a registered designated caregiver on behalf of a registered qualifying patient, may not possess more than seven and H. B. NO. 1203 - PAGE 2 one-half ounces [212.62 grams] of dried leaves or flowers of the plant of the genus cannabis in a combustible delivery form. (3) At any time, a registered qualifying patient, or a registered designated caregiver on behalf of a registered qualifying patient, may not possess more than five hundred milligrams of a cannabinoid edible product. c. A registered qualifying patient may not purchase or have purchased by a registered designated caregiver more than the maximum concentration or amount of tetrahydrocannabinol permitted in a thirty-day period. The maximum concentration or amount of tetrahydrocannabinol permitted in a thirty-day period for a cannabinoid concentrate or medical cannabinoid product, or the cumulative total of both, is six thousand milligrams. At any time, a registered qualifying patient, or a registered designated caregiver on behalf of a registered qualifying patient, may not purchase more than three hundred ten milligrams of tetrahydrocannabinol in the form of a cannabinoid edible product.”
With
References
- Norml. ND gov signs bill allowing medical cannabis edibles
https://norml.org/blog/2025/04/24/north-dakota-governor-signs-legislation-authorizing-patients-to-obtain-cannabis-infused-edible-products/ (accessed Apr 25, 2025). - ND - HB1203
https://www.billtrack50.com/billdetail/1774563 (accessed Apr 25, 2025).
Newsletter
Unlock the latest breakthroughs in cannabis science—subscribe now to get expert insights, research, and industry updates delivered to your inbox.